CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells

Journal of Neuroimmunology

Volumn 69, Issue 1-2, 1996, Pages 63-71

  Sawant Mane, Suneeti ^a   Piddlesden, Sara J ^b   Morgan, B Paul ^b   Holers, V Michael ^c   Koski, Carol Lee ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

complement; cytolysis; GPI linked proteins; Schwann cells

Indexed keywords

CD59 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; FLOW CYTOMETRY; GUILLAIN BARRE SYNDROME; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RAT; SCHWANN CELL;

ANIMALS; ANTIGENS, CD59; ANTIGENS, SURFACE; CELLS, CULTURED; COMPLEMENT C3; COMPLEMENT C8; COMPLEMENT C9; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; GUINEA PIGS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; SCHWANN CELLS; SCIATIC NERVE;

EID: 0030249606     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00048-3     Document Type: Article

References (34)

1. Ahearn, J.M. and Fearon, D.T. (1989) Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. in Immunol. 46, 183-219.
2. Arnason, B.G.W. (1984) Acute inflammatory demyelinating polyradiculoneuropathies in peripheral neuropathy. In P.J. Dyck, P.K. Thomas, E.H. Lambert and R. Bunge (Eds.), Peripheral Neuropathy, W.B. Saunders, Philadelphia, pp. 2050-2100.
3. Brockes, J. and Patt, M. (1979) Studies on cultured rat Schwann cells: Derivation of purified populations from cultures of peripheral nerve. Brain Res. 165, 105-118.
4. 2+. J. Immunol. 137, 263-270.
5. Feasby, T.E., Gilbert J.J., Hahn A.F., and Neilson, M. (1987) Complement depletion suppresses Lewis rat experimental allergic neuritis. Brain 19, 97-103.
6. Funabashi, K., Okada, N., Matsuo S., Yamamoto, T., Morgan, B.P. and Okada, H. (1994) Tissue distribution of complement regulatory membrane proteins in rats. Immunology 81, 444-512.
7. Hartung, H.P. (1993) Immune-mediated demyelination [comment]. [Review] Ann Neurol. 33, 591-596.
8. Hughes, T.R., Piddlesden, S.J., Williams, J.D., Harrison R.A. and Morgan, B.P. (1992) Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem. J. 284, 169-176.
9. Johnson, E., Berge, V. and Hogasen, K. (1994) Formation of the terminal complement complex on agarose beads: further evidence that vitronectin (complement S-protein) inhibits C9 polymerization. Scand. J. Immunol. 39, 281-285.
10. Kim, Y.U., Kinoshita, T., Molina, H., Hourcade, D., Seya, T., Wagner, L.M. and Holers, V.M. (1995) Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181, 151-159.
11. Koski, C.L., Vanguri, P. and Shin, M.L. (1985) Activation of the alternative pathway of complement by human peripheral nerve myelin. J. Immunol. 134, 1810-1814.
12. Koski, C.L., Estep, A.E., Sawant-Mane, S., Shin, M.L., Highbarger, L. and Hansch, G.M. (1996) Complement regulatory molecules on human myelin and glial cells: Differential expression affects the deposition of activated complement proteins. J. Neurochem. 66, 303-312.
13. Lisanti, M.P., Tang, Z.L. and Sargiacomo, M. (1993) Caveolin forms a hetero-oligomeric complex that interacts with an apical GPI-linked protein: implications for biogenesis of cavcolac. J. Cell Biol. 123, 595-604.
14. Maison, C.M., Villers, C.L. and Colomb, M.G. (1992) Proteolysis of C3 on U937 cell: plasma membrane purification of Cathepsin G. J. Immunol. 147, 921-927.
15. Markwell, M.A.K., Hass, S.M., Bieber, L.L. and Tolbert, N.E. (1978) A modification of Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210.
16. Nyland, H., Matre, R. and Mork, S. (1981) Immunological characterization of sural nerve biopsies from patients with Guillain-Barré Syndrome. Ann Neurol. 9 (Suppl.), 80-86.
17. Phillips, M.S., Stewart, S. and Anderson, J.R. (1984) Neuropathological findings in Miller Fisher syndrome. J. Neurol. Neursurg. Psychiatr. 47, 492-495.
18. Piddlesden, S.J. and Morgan, B.P. (1993) Killing of rat glial cells by complement: Deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J. Neuroimmunol. 48, 169-175.
19. Prineas, J.W. (1972) Acute idiopathic polyneuritis: an electron microscope study. Lab. Invest. 26, 133-147.
20. Prineas, J.W. (1981) Pathology of the Guillain-Barré syndrome. Ann. Neurol. 7, 6-9 (Suppl.).
21. Quigg, R.J., Galishoff, M.L., Sneed, A.E. III and Kim, D. (1993) Isolation and characterization of complement receptor type 1 from rat glomerular epithelial cells. Kidney Intnl. 43, 730-736.
22. Saida, T., Saida, K., Silberberg, D.H. and Brown, M.J. (1978) Transfer of demyelination by intraneural injection of experimental allergic neuritis serum. Nature 272, 639-641.
23. Saida, T., Saida, K., Lisak, R.P. et al. (1982) In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann. Neurol. 11, 69-75.
24. Sawant-Mane, S., Clark, M.B. and Koski, C.L. (1991) In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes. Ann. Neurol. 29, 397-404.
25. Sawant-Mane, S.S., Estep, A.E. III and Koski, C.L. (1994) Antibody of patients with Guillain Barre syndrome mediates complement dependent cytolysis of rat Schwann cells: Susceptibility to cytolysis reflects Schwann cell phenotype. J. Neuroimmunol. 49, 145-152.
26. Scolding, N.J., Morgan, B.P., Houston, W.A.J., et al. (1989) Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 339, 620-622.
27. Spicer, A.P., Seldin, M.F. and Gendler, S.J. (1995) Molecular cloning and chromosomal localization of the mouse decay accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J. Immunol. 155, 3079-3091.
28. Stoll, S., Schmidt, B., Jander, S., Toyka, K.V. and Hartung, H.P. (1991) Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of rat peripheral nervous system. Ann. Neurol. 30, 147-155.
29. Takizawa, H., Okada, N. and Okada, H. (1994) Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J. Immunol. 152, 3032-3038.
30. Thom, D., Powell, A.J., Lloyd, C.W. and Rees, D.A, (1977) Rapid isolation of plasma membrane in high yield from cultured fibroblasts. Biochem. J. 168, 187-194.
31. Tschopp, J., Chonn, A., Hertig, S. and French, L.E. (1993) Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J. Immunology 151, 2159-2165.
32. Vriesendorp, F.J., Flynn, R.E., Papolla, MA. and Koski, C.L. (1995) Complement depletion affects demyelination and inflammation in experimental allergic neuritis. J. Neuroimmunol. 58, 157-165.
33. Wren, D.R. and Noble, M. (1989) Oligodendrocytes and oligodendrocyte/type-2 astiocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in the absence of antibody. Pro. Natl. Acad. Sci. 86, 9025-9029.
34. Young, I.T. (1977) Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J. Histochem. Cytochem. 25, 935-941.